Table 1

Antimicrobial Resistance in ESBL-producing E. coli from Blood (Nā€‰=ā€‰15) and Urinary (Nā€‰=ā€‰366)
Susceptible (%) Intermediate (%) Resistant (%)
Blood Urine Blood Urine Blood Urine
Amikacin 11 (78.6) 312 (86.4) 2 (14) 29 (8.0) 1 (7.1) 20 (5.5)
Gentamicin 9 (60.0) 254 (70.2) 1 (7) 3 (0.8) 5 (33.3) 105 (29.0)
Ciprofloxacin 0 (0) 62 (17.0) 0 (0) 1 (0.3) 15 (100) 302 (82.7)
Meropenem 15 (100) - 0 (0) - 0 (0) -
Trimethoprim - 68 (18.6) - 0 (0) - 297 (81.4)
Nalidixic Acid - 43 (11.8) - 1 (0.3) - 319 (87.9)
Nitrofurantoin - 323 (88.5) - 20 (5.5) - 22 (6.0)

Legend to Table 1. Susceptibility, Intermediate and Resistance to non-beta-lactam antimicrobial agents by Clinical Laboratory Standards Institute criteria for ESBL producing E. coli for the period July 2004 to December 2008. Note: one or more isolates had incomplete susceptibility data therefore the totals for each row do not fully correspond.

Fennell et al.

Fennell et al. BMC Infectious Diseases 2012 12:116   doi:10.1186/1471-2334-12-116

Open Data